Incyte's povorcitinib met key Phase 3 trial endpoints in hidradenitis suppurativa, showing significant clinical response and a well-tolerated safety profile.

With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving ...

Bangladesh took a decisive step toward tougher justice for women and children on Monday, March 17, as the government ...

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second p ...

To pave the way for the deployment of the 5G Non-Terrestrial Network (NTN) standards, the Industrial Technology Research ...

Former Utah representative Mia Love, the first black Republican woman elected to Congress , was diagnosed with glioblastoma, ...

The opportunity to curl in his home province is something Brett Gallant does not take for granted. Gallant and his wife, ...

Chemours, a global leader in delivering innovative performance chemistry, today announced the launch of a full-scale product trial with NTT DATA and a leading regional engineering firm, Hibiya ...

Press Release 4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will receive USD 400 million upfront, with the potential ...

Richard R. Laird’s quest to be removed from death row for the Anthony Milano murder suffered a major blow last month.